Ju Mei

982 total citations
37 papers, 750 citations indexed

About

Ju Mei is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Ju Mei has authored 37 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 15 papers in Pulmonary and Respiratory Medicine and 15 papers in Cancer Research. Recurrent topics in Ju Mei's work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (7 papers) and RNA modifications and cancer (6 papers). Ju Mei is often cited by papers focused on MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (7 papers) and RNA modifications and cancer (6 papers). Ju Mei collaborates with scholars based in China. Ju Mei's co-authors include Fangbao Ding, Haibo Xiao, Xiao Xie, Fengqing Hu, Lianyong Jiang, Rui Bi, Mingsong Wang, Nan Ma, Zhiwei Xu and Yan Tan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Ju Mei

33 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ju Mei China 19 520 314 160 117 85 37 750
Qiong Xu China 13 550 1.1× 288 0.9× 53 0.3× 96 0.8× 76 0.9× 29 724
Marie O’Farrell United States 9 486 0.9× 426 1.4× 87 0.5× 126 1.1× 253 3.0× 25 901
Fuchen Liu China 15 373 0.7× 235 0.7× 124 0.8× 108 0.9× 127 1.5× 51 727
Liuxin Cai China 10 381 0.7× 205 0.7× 157 1.0× 208 1.8× 55 0.6× 18 712
Weihao Li China 14 558 1.1× 435 1.4× 119 0.7× 135 1.2× 46 0.5× 40 816
Ren Zhao China 15 721 1.4× 279 0.9× 191 1.2× 212 1.8× 79 0.9× 36 993
Paola Mazzarelli Italy 15 748 1.4× 342 1.1× 91 0.6× 233 2.0× 55 0.6× 22 1.0k
Xianqiu Wu China 15 483 0.9× 223 0.7× 115 0.7× 193 1.6× 59 0.7× 26 740
Ryan W. Askeland United States 15 486 0.9× 307 1.0× 87 0.5× 160 1.4× 33 0.4× 29 771

Countries citing papers authored by Ju Mei

Since Specialization
Citations

This map shows the geographic impact of Ju Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju Mei more than expected).

Fields of papers citing papers by Ju Mei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ju Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju Mei. The network helps show where Ju Mei may publish in the future.

Co-authorship network of co-authors of Ju Mei

This figure shows the co-authorship network connecting the top 25 collaborators of Ju Mei. A scholar is included among the top collaborators of Ju Mei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ju Mei. Ju Mei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bi, Rui, et al.. (2024). Butyrate attenuates the stemness of lung cancer cells through lysosome Fe2+- and SLC7A11-mediated ferroptosis. Heliyon. 10(7). e28093–e28093. 4 indexed citations
3.
Bi, Rui, Rui Hu, Lianyong Jiang, et al.. (2023). Butyrate enhances erastin‐induced ferroptosis of lung cancer cells via modulating the ATF3/SLC7A11 pathway. Environmental Toxicology. 39(2). 529–538. 27 indexed citations
4.
Huang, Dandan, et al.. (2020). Induction of Autophagy by Baicalin Through the AMPK-mTOR Pathway Protects Human Skin Fibroblasts from Ultraviolet B Radiation-Induced Apoptosis. SHILAP Revista de lepidopterología. 2 indexed citations
5.
Xiao, Haibo, Qi Yang, Lianyong Jiang, et al.. (2020). The USP21/YY1/SNHG16 axis contributes to tumor proliferation, migration, and invasion of non-small-cell lung cancer. Experimental & Molecular Medicine. 52(1). 41–55. 63 indexed citations
6.
Jiang, Lianyong, Xiao Xie, Rui Bi, Fangbao Ding, & Ju Mei. (2020). Knockdown of Linc00511 inhibits TGF-β-induced cell migration and invasion by suppressing epithelial-mesenchymal transition and down-regulating MMPs expression. Biomedicine & Pharmacotherapy. 125. 109049–109049. 11 indexed citations
7.
Jiang, Zhaolei, et al.. (2017). Surgical Management of Giant Left Sinus of Valsalva Aneurysm Causing Left Anterior Descending Coronary Artery Occlusion. The Annals of Thoracic Surgery. 104(1). e27–e29. 2 indexed citations
8.
Xu, Zhiwei, Ju Mei, & Yan Tan. (2016). Baicalin attenuates DDP (cisplatin) resistance in lung cancer by downregulating MARK2 and p-Akt. International Journal of Oncology. 50(1). 93–100. 44 indexed citations
10.
Xiao, Haibo, Yang Yang, Fengqing Hu, et al.. (2015). USP22 acts as an oncogene by regulating the stability of cyclooxygenase-2 in non-small cell lung cancer. Biochemical and Biophysical Research Communications. 460(3). 703–708. 31 indexed citations
11.
Zhang, Yunjiao, Yi Si, Nan Ma, & Ju Mei. (2015). The RNA-binding protein PCBP2 inhibits Ang II-induced hypertrophy of cardiomyocytes though promoting GPR56 mRNA degeneration. Biochemical and Biophysical Research Communications. 464(3). 679–684. 36 indexed citations
12.
Zhu, Jiaquan, et al.. (2014). Aortico–Left Ventricular Tunnel Arising From the Noncoronary Sinus Associated With a Ventricular Septal Defect. The Annals of Thoracic Surgery. 98(6). e135–e137. 2 indexed citations
13.
Xie, Xiao, Haibo Xiao, Fangbao Ding, et al.. (2014). Over-expression of prolyl hydroxylase-1 blocks NF-κB-mediated cyclin D1 expression and proliferation in lung carcinoma cells. Cancer Genetics. 207(5). 188–194. 26 indexed citations
14.
Hu, Fengqing, Zhen Tao, Mingsong Wang, et al.. (2013). RACK1 promoted the growth and migration of the cancer cells in the progression of esophageal squamous cell carcinoma. Tumor Biology. 34(6). 3893–3899. 17 indexed citations
15.
Zhu, Jiaquan, et al.. (2013). Congenital quadricuspid aortic valve associated with aortic insufficiency and mitral regurgitation. Journal of Cardiothoracic Surgery. 8(1). 87–87. 15 indexed citations
16.
Mei, Ju. (2011). Expression of Survivin and its Correlation with VEGF in Non-small Cell Lung Cancer. Xiandai shengwu yixue jinzhan. 1 indexed citations
17.
Mei, Ju, et al.. (2011). Interferon-β efficiently inhibited endothelial progenitor cell-induced tumor angiogenesis. Gene Therapy. 19(10). 1030–1034. 18 indexed citations
18.
Lv, Zhongwei, Xiaoping Zhang, Jiaquan Zhu, et al.. (2011). Suppression of cardiac allograft vasculopathy in mice by inhibition of CC-motif chemokine receptor 5. Transplant Immunology. 26(2-3). 128–132. 1 indexed citations
19.
Ma, Nan, et al.. (2011). Bone marrow mesenchymal stem cells can differentiate into type II alveolar epithelial cellsin vitro. Cell Biology International. 35(12). 1261–1266. 45 indexed citations
20.
Wan, Jun, et al.. (2009). The effects of HIF-1alpha on gene expression profiles of NCI-H446 human small cell lung cancer cells. Journal of Experimental & Clinical Cancer Research. 28(1). 150–150. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026